Literature DB >> 27040060

Limited lymph node dissection in elderly patients with gastric cancer.

Kozo Yoshikawa1, Mitsuo Shimada, Jun Higashijima, Toshihiro Nakao, Masaaki Nishi, Hideya Kashihara, Chie Takasu.   

Abstract

BACKGROUND: The number of elderly patients with gastric cancer is continuing to increase along with the life expectancy of the general population. The purpose of this study was to investigate both the impact of age on postoperative outcome and the effect of limited lymph node dissection for elderly patients.
METHODS: Patients were classified into the following three groups: Group A, ≥80 years old (n=44); Group B, 70-80 years old (n=139); Group C, <70 years old (n=219). Postoperative complication and survival rates were compared between the three groups
Results: Limited lymph node dissection was performed significantly more frequently in Group A. In terms of surgery-related complications, no significant difference was seen between groups. In terms of general related complications, the complication rate increased with age, from 4% in Group C to 13% in Group B and 14% in Group A (p<0.05 each). Although limited lymph node dissection was frequently performed in Group A, cancer-specific survival showed no significant difference in R0 patients.
CONCLUSIONS: Limited lymph node dissection for gastric cancer did not affect the cancer-specific survival in elderly patients.

Entities:  

Mesh:

Year:  2016        PMID: 27040060     DOI: 10.2152/jmi.63.91

Source DB:  PubMed          Journal:  J Med Invest        ISSN: 1343-1420


  2 in total

1.  Is it safe to perform gastrectomy in gastric cancer patients aged 80 or older?: A meta-analysis and systematic review.

Authors:  Yixin Xu; Yibo Wang; Cheng Xi; Nianyuan Ye; Xuezhong Xu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

2.  A Novel Approach for Gastric Cancer Staging in Elderly Patients Based on the Lymph Node Ratio.

Authors:  Joonseon Park; Chul Hyo Jeon; So Jung Kim; Ho Seok Seo; Kyo Young Song; Han Hong Lee
Journal:  J Gastric Cancer       Date:  2021-03-26       Impact factor: 3.720

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.